Warren Linley is an accomplished health economist and market access specialist with extensive experience in the biopharma and life sciences sectors. Currently serving as the Director of HTA and Market Access Consulting at Paragon Market Access Ltd and as a member of the NICE Technology Appraisal Committee, Warren contributes to critical decision-making on medicines in England and Wales. Previous roles include Senior Director of Health Economics at Zogenix International and Director of Global Health Economics at Amgen, where leadership encompassed HTA strategy and local evidence generation. Warren's academic credentials include a PhD in Health Economics from Bangor University and an MBA from ThePowerMBA, supplemented by a BSc in Pharmacy from Liverpool John Moores University.
Sign up to view 0 direct reports
Get started
This person is not in any teams